Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Classement en actions #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Prix de l'action
$20.65
Dernière synchronisation: 2023-03-01
Capitalisation boursière
$82.52M
Changement (1 jour)
-0.58%
Changement (1 an)
0.00%
Pays
US
Échange Opiant Pharmaceuticals, Inc. (OPNT)

Catégorie

Le prix OPNT avec la capitalisation boursière de B
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
OPNT
$20.65
Capitalisation boursière de Opiant Pharmaceuticals, Inc.(OPNT)
Capitalisation boursière: $82.52M
En August 2026, Opiant Pharmaceuticals, Inc. a une capitalisation boursière de $82.52M. Cela fait de Opiant Pharmaceuticals, Inc. la 22841st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Opiant Pharmaceuticals, Inc. du 2017 au 2026
OPNT par rapport au top 5 des plus populaires stocks
Prix pour OPNT L’actif B La capitalisation boursière de B Résultats
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,304,152 $82.52M
$5.211T +6,315,404.91%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,137,829 $82.52M
$4.547T +5,509,967.93%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$1,041,665 $82.52M
$4.162T +5,044,282.38%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$899,100 $82.52M
$3.593T +4,353,897.56%
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.
$698,915 $82.52M
$2.793T +3,384,478.13%